Fundraising Fox

Kinnate Biopharma

San Diego, US · Founded 2018 · Delaware corporation · 6 known investors

Biotech

Founders & leadership

Kinnate Biopharma was founded in 2018 by Stephen W. Kaldor.

SW
Stephen W. KaldorFounder
EM
Eric MurphyNamed on SEC filing

Board

BZ
Bret ZbarBoard director
CG
Carl GordonBoard director
MR
Michael RomeBoard director

Investors · 6

Foresite CapitalWest Hollywoodvia Michael Rome · board
Nextech InvestZurich · $648K – $3.2M
Janus Henderson InvestorsreportedLondon
RA CapitalreportedBoston
Venrock Healthcare Capital PartnersreportedNew York
Viking Global InvestorsreportedStamford

Reported raises · per SEC filings

Form D private placements

$172.5M disclosed across 2 rounds · 2019–2020

▶$98MraisedAug 2020 · 24 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Keith FlahertyDirector
  • Mark MeltzExecutive Officer
  • Jim TananbaumDirector
  • Dean MitchellDirector
  • Stephen W. KaldorDirector, Promoter
  • Carl GordonDirector
  • Laurie Smaldone AlsupDirector
  • Michael RomeDirector
  • Nima FarzanExecutive Officer, Director
Offering amount
$98M
Amount sold
$98M
First sale
Jul 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$74.5MraisedDec 2019 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen W. KaldorExecutive Officer, Director, Promoter
  • Eric MurphyExecutive Officer, Director
  • Bret ZbarDirector
  • Carl GordonDirector
  • Michael RomeDirector
Offering amount
$74.5M
Amount sold
$74.5M
First sale
Dec 2019
Incorporated
Corporation, California, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Latigo Nets $346 Million from Public Offering - Los Angeles Business Journallabusinessjournal.com · Aug 2026Kinnate Biopharma Raises $35M to Establish Chinese Joint Venture | Precision Medicine Onlineprecisionmedicineonline.com · May 2021Kinnate Biopharma Raises $98M in Series C Financing Round - BioSpacebiospace.com · Aug 2020Kinnate bags $98M to push next-gen targeted cancer meds into the clinic | Fierce Biotechfiercebiotech.com · Aug 2020Kinnate Biopharma Raises $74.5M in Series B Financing - FinSMEsfinsmes.com · Dec 2019

Frequently asked questions

Who founded Kinnate Biopharma?
Kinnate Biopharma was founded by Stephen W. Kaldor in 2018.
Who are Kinnate Biopharma's investors?
Kinnate Biopharma's investors include Foresite Capital, Nextech Invest, Janus Henderson Investors, RA Capital, Venrock Healthcare Capital Partners, Viking Global Investors.
How much funding has Kinnate Biopharma raised?
Kinnate Biopharma has disclosed $172.5M raised across 2 rounds.
Where is Kinnate Biopharma headquartered?
Kinnate Biopharma is headquartered in San Diego, US.